Results 81 to 90 of about 134,380 (103)

Evolving Management Approaches Toward Personalized Therapy in Acute Myeloid Leukemia: A Narrative Review. [PDF]

J Pers Med
Niscola P, Gianfelici V, Giovannini M, Mazzone C, Principe MID.   +4 more
europepmc   +1 more source

When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia. [PDF]

Curr Hematol Malig Rep
Benrashid S, Woyach JA.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11

Journal of Drug Targeting, 2021
Yang Cai, Dezhi Huang, Wenjia Ma
exaly  

Bim transfer between Bcl-2-like protein and Hsp70 underlines Bcl-2/Hsp70 crosstalk to regulate apoptosis

Biochemical Pharmacology, 2021
Zongwei Guo, Yafei Guo, Ting Song
exaly  

Chemical shift assignments of a fusion protein comprising the C-terminal-deleted hepatitis B virus X protein BH3-like motif peptide and Bcl-xL

Biomolecular NMR Assignments, 2022
Hideki Kusunoki, Isao Hamaguchi, Naohiro Kobayashi   +2 more
exaly  

BCL‐2‐family protein tBID can act as a BAX‐like effector of apoptosis

EMBO Journal, 2022
Hector Flores-Romero, Lisa Hohorst, Malina John   +2 more
exaly  

Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases

Oncogene, 1998
Naoya Fujita, Susumu Rokudai, Takashi Tsuruo   +2 more
exaly  

Identification and function analysis of the host cell protein that interacted with Orf virus Bcl-2-like protein ORFV125

Research in Veterinary Science, 2016
Jinyan Wu
exaly  

NMR characterization of the interaction between Bcl-xL and the BH3-like motif of hepatitis B virus X protein

Biochemical and Biophysical Research Communications, 2019
Hideki Kusunoki, Toshiyuki Kohno, Kazuo Hosoda   +2 more
exaly